Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix
Clinical trial NCT00946556 · COMPLETED
Trial details
- NCT number
- NCT00946556
- Sponsor
- University of Toronto
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.